Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open‐label, and single‐arm Phase 1 study
- Resource Type
- article
- Source
- Clinical and Translational Medicine, Vol 13, Iss 8, Pp n/a-n/a (2023)
- Subject
Medicine (General) R5-920 - Language
- English
- ISSN
- 2001-1326